Current Report Filing (8-k)
06 Junio 2019 - 3:36PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 6, 2019
VITAMIN SHOPPE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
Delaware
|
|
001-34507
|
|
11-3664322
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
300 Harmon Meadow Blvd.
Secaucus, New Jersey 07094
(Address of Principal Executive Offices, including Zip Code)
(201)
868-5959
(Registrant’s Telephone Number, including Area Code)
Not Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the appropriate box below
if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17
CFR
240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
|
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange
on which registered
|
|
Common Stock, $0.01 par value per share
|
|
VSI
|
|
The New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
|
ITEM 5.07
|
Submission of Matters to a Vote of Security Holders.
|
|
|
(a)
|
The Annual Meeting of Vitamin Shoppe, Inc. (the “Company”) was held on June 5, 2019 (the
“Annual Meeting”).
|
|
|
(b)
|
The final voting results for each of the matters submitted to a vote of the stockholders of the Company at the
Annual Meeting were as follows:
|
Proposal 1 – Election of Directors.
The final results of the voting for nine (9) Directors for an annual term are set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR
|
|
|
AGAINST
|
|
|
ABSTAIN
|
|
|
NON-VOTES
|
|
|
Deborah M. Derby
|
|
|
15,891,370
|
|
|
|
380,741
|
|
|
|
11,366
|
|
|
|
5,249,367
|
|
|
David H. Edwab
|
|
|
15,695,254
|
|
|
|
576,825
|
|
|
|
11,398
|
|
|
|
5,249,367
|
|
|
Melvin L. Keating
|
|
|
15,913,338
|
|
|
|
364,215
|
|
|
|
5,924
|
|
|
|
5,249,367
|
|
|
Sharon M. Leite
|
|
|
15,879,124
|
|
|
|
388,163
|
|
|
|
16,190
|
|
|
|
5,249,367
|
|
|
Guillermo G. Marmol
|
|
|
15,884,494
|
|
|
|
387,605
|
|
|
|
11,378
|
|
|
|
5,249,367
|
|
|
Himanshu H. Shah
|
|
|
16,142,172
|
|
|
|
129,909
|
|
|
|
11,396
|
|
|
|
5,249,367
|
|
|
Alexander W. Smith
|
|
|
15,832,998
|
|
|
|
439,279
|
|
|
|
11,200
|
|
|
|
5,249,367
|
|
|
Timothy J. Theriault
|
|
|
15,868,187
|
|
|
|
403,882
|
|
|
|
11,408
|
|
|
|
5,249,367
|
|
|
Sing Wang
|
|
|
15,688,582
|
|
|
|
583,222
|
|
|
|
11,673
|
|
|
|
5,249,367
|
|
Proposal 2 – Advisory and
Non-Binding
Vote to Approve Named Executive Officer
Compensation.
The Company’s stockholders approved, on an advisory,
non-binding
basis, the
compensation of our named executive officers based upon the following votes:
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Non-Votes
|
|
15,481,044
|
|
490,797
|
|
311,636
|
|
5,249,367
|
Proposal 3 – Vote to Ratify the Appointment of Deloitte & Touche LLP as the Company’s Independent
Registered Public Accounting Firm for the 2019 Fiscal Year.
The stockholders ratified the appointment of Deloitte & Touche
LLP as the Company’s independent registered public accounting firm for the 2019 fiscal year based upon the following votes:
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Non-Votes
|
|
21,083,230
|
|
442,462
|
|
7,152
|
|
0
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VITAMIN SHOPPE, INC.
|
|
|
|
|
|
|
Date: June 6, 2019
|
|
|
|
By:
|
|
/s/ David M. Kastin
|
|
|
|
|
|
|
|
Name:
|
|
David M. Kastin
|
|
|
|
|
|
|
|
Title:
|
|
Senior Vice President, General Counsel and Corporate Secretary
|
Vitamin Shoppe (NYSE:VSI)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Vitamin Shoppe (NYSE:VSI)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
